Avalide (Irbesartan-Hydrochlorothiazide)

Avalide is a combination medication used to treat hypertension (high blood pressure). It was originally developed through a partnership between the French pharmaceutical giant Sanofi-Synthelabo and the American company Bristol-Myers Squibb. While the original drug was patented by these companies, it is now widely available in generic forms like the Irbesartan-HCTZ shown on the label.

Manufacturing for this medication takes place in various global facilities owned by Sanofi and Bristol-Myers Squibb, or their licensed generic manufacturers, across Europe, North America, and Asia. Today, Sanofi remains the primary ultimate owner of the brand name and the original formulation, operating as a top-tier global healthcare company with headquarters in Paris, France. In many regions, local pharmacies or generic distributors handle the final dispensing and local labeling of the product.